Korean J Urol.  2001 Jan;42(1):120-123.

T-cell Lymphoma of the prostate: Remission with Doxorubicin-Based Combination Chemotherapy

Abstract

Lymphoma of the prostate is exceedingly rare. Much more common than primary lymphoma of the prostate id secondary involvement of malignant lymphomas originating at other sites. A variety of treatments have bee n used, including prostatectomy, radiotherapy or combinations of chemotherapy and radiotherapy. Generally, the prognosis is very poor, and there is currently no consensus regarding treatment. We report on a patient with T-cell lymphoma who presented with symptoms of bladder neck obstruction. The patient has been asymptomatic and under complete remission after completion of doxorubicin-based chemotherapy for 2 cycles.

Keyword

Prostate; Tumor; Lymphoma; Chemotherapy

MeSH Terms

Bees
Consensus
Drug Therapy
Drug Therapy, Combination*
Humans
Lymphoma
Lymphoma, T-Cell*
Prognosis
Prostate*
Prostatectomy
Radiotherapy
T-Lymphocytes*
Urinary Bladder Neck Obstruction
Full Text Links
  • KJU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr